Transcriptomic Heterogeneity of Favorable-risk Prostate Cancer: Time To Move Past Cancer of the Prostate Risk Assessment (CAPRA) to Clinical-genomic Risk

Daniel E. Spratt; Edward M. Schaeffer

doi:10.1016/j.eururo.2018.06.001

Transcriptomic Heterogeneity of Favorable-risk Prostate Cancer: Time To Move Past Cancer of the Prostate Risk Assessment (CAPRA) to Clinical-genomic Risk

Daniel E. Spratt, Edward M. Schaeffer^*

^*Corresponding author for this work

Urology

Research output: Contribution to journal › Editorial › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	453-454
Number of pages	2
Journal	European urology
Volume	74
Issue number	4
DOIs	https://doi.org/10.1016/j.eururo.2018.06.001
State	Published - Oct 2018

ASJC Scopus subject areas

Urology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.eururo.2018.06.001

Cite this

@article{2e2e933e51364748be3910f9d82cc4b6,

title = "Transcriptomic Heterogeneity of Favorable-risk Prostate Cancer: Time To Move Past Cancer of the Prostate Risk Assessment (CAPRA) to Clinical-genomic Risk",

author = "Spratt, {Daniel E.} and Schaeffer, {Edward M.}",

year = "2018",

month = oct,

doi = "10.1016/j.eururo.2018.06.001",

language = "English (US)",

volume = "74",

pages = "453--454",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - Transcriptomic Heterogeneity of Favorable-risk Prostate Cancer

T2 - Time To Move Past Cancer of the Prostate Risk Assessment (CAPRA) to Clinical-genomic Risk

AU - Spratt, Daniel E.

AU - Schaeffer, Edward M.

PY - 2018/10

Y1 - 2018/10

UR - http://www.scopus.com/inward/record.url?scp=85048317389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048317389&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2018.06.001

DO - 10.1016/j.eururo.2018.06.001

M3 - Editorial

C2 - 29907357

AN - SCOPUS:85048317389

SN - 0302-2838

VL - 74

SP - 453

EP - 454

JO - European Urology

JF - European Urology

IS - 4

ER -

Transcriptomic Heterogeneity of Favorable-risk Prostate Cancer: Time To Move Past Cancer of the Prostate Risk Assessment (CAPRA) to Clinical-genomic Risk

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this